Literature DB >> 10399711

Practical evaluation of standard-based low-cost video conferencing in telemedicine and epidemiological applications.

P J Klutke1, J G Gostomzyk, P Mattioli, F Baruffaldi, A Plasencia, C Borrell, M Pasarin, E Di Crescenzo, E Pipitone, C Mancini, A Toschi, M Morshedi, M G Strintzis, K H Englmeier.   

Abstract

The results of the evaluation of use of low-cost video conferencing systems (VCSs) in telemedicine is presented. Applications sharing, a new feature of these systems, recently has allowed high-quality computer-supported collaborative work (CSCW). The video conferencing (VCing) equipment used was Intel ProShare 200 v2.0a. It is representative of other low-cost VCSs. The areas of application are epidemiology and telemedicine (orthopaedics and radiology). Potential end users filled out 58 evaluation questionnaires concerning user profiles, contents and benefits of the sessions, organizational aspects, user friendliness, user acceptance, cost effectiveness, technical and multipoint related aspects. Although the end users had a lot of computer experience, their knowledge in VCSs was rather limited. The users assessed the system capable of being integrated into routine work, despite a high organizational impact. The VCS is user friendly, application sharing being used in almost every session. Audio quality was not always sufficient. The remote video was sufficient, as was the quality of medical images such as CT, MRI or X-ray. The user acceptance of the system was high. Multipoint sessions require a structured protocol to be effective. Some technical problems with MCUs (Multipoint Control Units) occurred. The use of low-cost standard VCSs in telemedicine is advisable and is a good substitute for real meetings.

Mesh:

Year:  1999        PMID: 10399711     DOI: 10.1080/146392399298474

Source DB:  PubMed          Journal:  Med Inform Internet Med        ISSN: 1463-9238


  1 in total

1.  A method to convert HDTV videos of broadcast satellite to RealSystem multimedia contents.

Authors:  Tomoko Yamakawa; Masao Hashiba; Tsukasa Koyama; Kouhei Akazawa
Journal:  J Med Syst       Date:  2002-10       Impact factor: 4.460

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.